City

Hong Kong (1)

Taipei (1)

Condition

Gastric Cancer in Situ (2)

Biliary Cancers (1)

Gastric Dysplasia (1)

Pancreatic Cancers (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

n/a (1)

phase 1 (1)

Sponsor

Chinese University of Hong Kong (1)

National Health Research Institutes, Taiwan (1)

Collaborator

National Cheng-Kung University Hospital (1)

National Taiwan University Hospital (1)

Intervention

albumin-bound paclitaxel /nab-paclitaxel (1)

endoscopic closure of esd defect (1)

gastric esd without closure of esd defect (1)

lv (1)

oxaliplatin (1)

s-1 (1)

Study Documents

Intervention Type

drug (1)

other (1)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

gastric cancer in situ

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Gastric Cancer in Situ, Pancreatic Cancers, Biliary Cancers Trial in Taipei (Oxaliplatin, Albumin-Bound Paclitaxel

Completed

Gastric Cancer in Situ
+2 more

Oxaliplatin
+3 more

Taipei, Taiwan

Taiwan Cooperative Oncology Group, National Health Research Inst

Apr 5, 2022

Gastric Dysplasia, Gastric Cancer in Situ Trial in Hong Kong (Endoscopic closure of ESD defect, Gastric ESD without closure of

Recruiting

Gastric Dysplasia
Gastric Cancer in Situ

Endoscopic closure of ESD defect
Gastric ESD without closure of ESD defect

Hong Kong, Hong Kong

The Chinese University of Hong Kong

Aug 2, 2021